🇺🇸 FDA
Patent

US 9890126

Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

granted A61KA61K31/4164A61K31/4174

Quick answer

US patent 9890126 (Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)) held by Beryllium Discovery Corp. expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beryllium Discovery Corp.
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/4164, A61K31/4174, A61K31/4178, A61K31/506